Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (51-60 of 374) with videos related to

Pageof 38
Sort By:
Core Evidence|November 7, 2019
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapyAdam D Taylor, Kenneth G Saag
Arthritis|March 15, 2018
Healthcare Providers' Recommendations for Physical Activity among US Arthritis Population: A Cross-Sectional Analysis by Race/EthnicityShamly Austin, Kenneth G Saag, Maria Pisu
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Osteoporotic fractures in older adultsCathleen S Colón-Emeric, Kenneth G Saag
The Journal of Rheumatology|October 3, 2013
Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfectKenneth G Saag, Jeffrey Curtis, Amy Warriner
The New England Journal of Medicine|January 11, 2018
Romosozumab versus Alendronate and Fracture Risk in Women with OsteoporosisKenneth G Saag, Jeffrey Petersen, Andreas Grauer
Annals of Internal Medicine|August 8, 2022
Unintended Consequences of SCOTUS Abortion Decision for Patients With Rheumatic DiseasesMegan E B Clowse, Kenneth G Saag
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 13, 2006
Treatment of rheumatoid arthritisAngelo Gaffo, Kenneth G Saag, Jeffrey R Curtis
Drugs|September 8, 2006
Pathophysiology, clinical presentation and treatment of goutGim Gee Teng, Raj Nair, Kenneth G Saag
Therapeutic Advances in Musculoskeletal Disease|July 20, 2018
Improving drug adherence in osteoporosis: an update on more recent studiesAyesha Jaleel, Kenneth G Saag, Maria I Danila
Rheumatic Diseases Clinics of North America|October 26, 2011
Long-term safety concerns of antiresorptive therapyJie Zhang, Kenneth G Saag, Jeffrey R Curtis
Pageof 38

Showing results (51-60 of 374) with videos related to

Sort By:
Pageof 38
Core Evidence|November 7, 2019
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapyAdam D Taylor, Kenneth G Saag
Arthritis|March 15, 2018
Healthcare Providers' Recommendations for Physical Activity among US Arthritis Population: A Cross-Sectional Analysis by Race/EthnicityShamly Austin, Kenneth G Saag, Maria Pisu
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Osteoporotic fractures in older adultsCathleen S Colón-Emeric, Kenneth G Saag
The Journal of Rheumatology|October 3, 2013
Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfectKenneth G Saag, Jeffrey Curtis, Amy Warriner
The New England Journal of Medicine|January 11, 2018
Romosozumab versus Alendronate and Fracture Risk in Women with OsteoporosisKenneth G Saag, Jeffrey Petersen, Andreas Grauer
Annals of Internal Medicine|August 8, 2022
Unintended Consequences of SCOTUS Abortion Decision for Patients With Rheumatic DiseasesMegan E B Clowse, Kenneth G Saag
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 13, 2006
Treatment of rheumatoid arthritisAngelo Gaffo, Kenneth G Saag, Jeffrey R Curtis
Drugs|September 8, 2006
Pathophysiology, clinical presentation and treatment of goutGim Gee Teng, Raj Nair, Kenneth G Saag
Therapeutic Advances in Musculoskeletal Disease|July 20, 2018
Improving drug adherence in osteoporosis: an update on more recent studiesAyesha Jaleel, Kenneth G Saag, Maria I Danila
Rheumatic Diseases Clinics of North America|October 26, 2011
Long-term safety concerns of antiresorptive therapyJie Zhang, Kenneth G Saag, Jeffrey R Curtis
Pageof 38